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Abstract
Background: Sedentary lifestyle, psychological stress and labor saving devices in this current society often disrupts the
energy gain and expenditure balance leading to obesity. High caloric diet is associated with the high prevalence of
cognitive dysfunction and neuropsychiatric disorders in addition to cardiovascular and metabolic abnormalities. The
present study was aimed to elucidate the potential beneficial effect of dry leaf powder of Withania somnifera
(Ashwagandha) in preventing the cognitive decline associated with diet induced obesity.
Methods: Experiments were performed on four groups of young adult female rats: [Low fat diet (LFD) rats fed on
regular low fat chow, High fat diet (HFD) rats on feed containing 30% fat by weight, Low fat diet extract (LFDE) rats
given regular chow and dry leaf powder of Ashwagandha 1 mg/g of body weight (ASH) and high fat diet extract
(HFDE) rats fed on diet containing high fat and dry leaf powder of ASH. All the rats were kept on their respective diet
regimen for 12 weeks.
Results: ASH treated rats showed significant improvement in their working memory and locomotor coordination
during behavioral studies as compared to HFD rats. At the molecular level, ASH treatment was observed to restore the
levels of BDNF and its receptor TRKB as well as the expression of other synaptic regulators, which are highly implicated
in synaptic plasticity. Further, ASH triggered the activation of PI3/AKT pathway of cell survival and plasticity by
enhancing the levels of phosphorylated Akt-1 and immediate early genes viz. c-Jun and c-fos.
Conclusions: ASH could be a key regulator in maintaining the synaptic plasticity in HFD induced obesity and can
serve as a nootropic candidate against obesity induced cognitive impairments.
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Background
Modern lifestyle and psychological stress has drastically
increased the consumption of palatable and high caloric
diet, leading to increasing rates of overweight and obesity
like conditions [1]. High caloric diet is associated with the
risk factors for various neuropsychiatric disorders such as
compulsive overeating, depression like behavior and cog-
nitive dysfunctions in addition to metabolic and cardiac
risks [2]. Recent studies have considered obesity and psy-
chiatric comorbidities as public health problems of high
relevance [3–5]. However, the cause or effect in relation to
mood disorders and obesity is still a question of active
interest? It is therefore important to identify the dynamics
of development of such neuropsychiatric alterations and
the underlying pathophysiological mechanisms in the
context of obesity. Cognitive disturbances in the obese
population include executive functioning such as problem
solving, working memory and neuro-muscular coordin-
ation which in turn affect the social and mental ability of
the obese individuals. Progress in the basic and clinical
research has revealed that obesity is not only a metabolic
disorder but it has been associated with low-grade inflam-
matory conditions leading to the immune system
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dysfunction. Accumulated evidence has revealed positive
associations between peripheral inflammatory status and
cognitive decline in obesity [6–8]. Various cross sectional
and longitudinal studies have also reported the association
of obesity (without any comorbid medical condition) with
cognitive deficits across the lifespan from childhood to
adolescence and from adulthood to old age [9, 10]. Poor
performance in overweight/obese children further also
suggests a bidirectional link.
In Ayurvedic medicine,Withania somnifera (Ashwagandha)
is commonly being used for its broad spectrum of pharmaco-
logical actions. Ashwagandha is traditionally used as a
rasayana (tonic) that works in a holistic manner to promote
overall health and vitality. The methanolic extracts of different
parts of Ashwagandha are known to exhibit therapeutic po-
tential against various types of cardiovascular comorbidities
and are also effective against hyperlipidemia and obesity [11].
Ashwagandha is known for its memory boosting and restora-
tive functions [12–15] and is also reported to reverse loss of
memory in mice model of Alzheimer’s disease by promoting
the neurogenesis and growth of brain cells [16]. Similarly root
extract of the plant and one of its active component withano-
lide A has been shown to improve spatial memory and cogni-
tive deficits in temporal lobe epilepsy and experimental model
of stroke [17, 18].
The present study was designed to investigate the poten-
tial beneficial effects of dry leaf powder of Ashwagandha in
redemption of cognitive skills and neuro-muscular func-
tions which are impaired by diet induced obesity (DIO). In
Ayurvedic Traditional Medicinal System, natural products
are used as dry powder or crude extract and their use is
based on holistic approach. Bioactivity of a particular
compound is usually not assigned. Majority of studies on
Ashwagandha have evaluated its efficacy for anti-cancer
and neuroprotective activities using root based ethanolic
and methanolic extracts as compared to water based for-
mulations [14, 19, 20]. Our lab is particularly using dry leaf
powder and water based crude formulations of leaves as
compared to root based alcoholic extracts with an aim to
scientifically validate the traditional use of Ashwagandha.
Moreover, the use of leaf powder and crude water extract
is both eco-friendly and bio-friendly as there is no need to
sacrifice the plant or use organic solvents for extraction
unlike root based alcoholic formulations. Additionally, the
use of powder or water based extract is convenient, safe
and easy to prepare.
Rats were divided into four groups: Low fat diet (LFD) on
regular chow, High fat diet (HFD) group on feed containing
30% fat by weight, Low fat diet extract (LFDE) group on
regular chow and dry leaf powder of Ashwagandha (ASH)
and high fat diet extract (HFDE) group on diet containing
high fat and ASH. The rationale of including LFDE group
in the present study was to explore any additional beneficial
effect of ASH in rats consuming normal and healthy diet
unlike rats fed with HFD. Interestingly, we found
significant changes in some behavioral tests and their
underlying molecular changes in this particular group.
Therefore we presented LFDE data where we observed sig-
nificant changes in this group. Post-regimen, all the rats
were subjected to behavioral tests such as Novel object rec-
ognition (NOR), Rotarod and Narrow beam walk. The
underlying molecular mechanism of the behavioral alter-
ations was further explored by evaluating the expression of
synaptic plasticity marker proteins such as polysialylated
neural cell adhesion molecule (PSA-NCAM), neural cell
adhesion molecule (NCAM) and calcium dependent synap-
tic regulators such as CaMKIIα and Calcineurin in hippo-
campus and pyriform cortex (PC) regions of the brain from
these rats. The BDNF pathway of synaptic plasticity and
PI3K/AKT pathway of cell survival pathway was studied in
detail along with transcription factors and immediate early
genes (IEGs) c-Jun and c-fos to elucidate the effect of
Ashwagandha leaf powder on these effector molecules in
ameliorating the impairments associated with DIO.
Methods
Collection and preparation of dry leaf powder of
Ashwagandha
The leaves were collected from the seed raised Ashwagandha
plant growing at the herbarium of the Department of
Botanical and Environmental Sciences, Guru Nanak Dev
University, Amritsar, India. The plant was identified and
authenticated by the plant taxonomist and a voucher spe-
cimen was deposited in the herbarium for the reference
purpose with deposition no. 401-24/07/1982. Our previ-
ous lab studies standardized and reported the in vivo dose
of water extract of Ashwagandha (ASH-WEX), but in the
present study, we used dry leaf powder of ASH. The dose
of ASH powder for the current study was calculated based
on our previous in vivo report [21, 22] using ASH-WEX
(dry weight) at a dose of 35 mg/250 g BW of the animal.
Given that 1 mg of dry weight of ASH-WEX is equivalent
to 6.80 mg of dry leaf powder, so the dose corresponds to
238 mg/250 g or ~1 g/kg or 1 mg/g BW of the animal as
standardized in our previous studies. The composition of
ASH-WEX has been characterized and reported in our
previous study [23].
Experimental conditions
Wistar albino young female rats in the age group of 3–4
months with body weight in range of 130–150 g were used
for all the experiments. All rats were caged in the group of
three under controlled conditions with temperature of
25 ± 2 C and dark/light cycle of 12:12 h with ad libitum
access to food and water. Rats were divided into four
groups: Low fat diet (LFD) on regular chow, High fat diet
(HFD) group on feed containing 30% fat by weight, Low
fat diet extract (LFDE) group on regular chow and dry leaf
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powder of Ashwagandha (ASH) and high fat diet extract
(HFDE) group on diet containing high fat and ASH. The
leaf powder was mixed in regular chow and high fat diet
at a concentration of 1 mg/g of body weight of the animal.
All the rats were kept on their respective diet regimen for
12 weeks and they were assessed for the weight gain once
after every week. All procedures of animal handling and
experiments were conducted in accordance with the
guidelines laid down by the Institutional Animal Ethical
Committee (IAEC) of Guru Nanak Dev University,
Amritsar, Punjab, India and complied with arrived
guidelines.
Blood glucose and corticosterone test
The blood glucose levels of all the rats were evaluated
once after every 15 day till the end of the regimen. The
rats were subjected to fasting for 12–14 h before the
blood glucose test. The glucose level was assessed by
using glucometer by collecting small amount of blood
from the animal. The corticosterone levels were analyzed
from serum collected at the time of experiment post
12 weeks diet regimen, irrespective of the phase of es-
trous cycle using corticosterone ELISA kit by Cayman
chemicals (USA) as per the manufacturer’s protocol.
Behavioral studies
Rotarod test
Rotarod apparatus was an automatic motor-driven tread-
mill (Rotamex-5; Columbus Instruments) consisting of a
7.0 × 9.5 cm spindle diameter with a fall height of 44.5 cm
from the center. The Rotarod test was performed on each
animal at a fixed speed of 10 rpm for duration of 300 s.
The number of falls and the time spent on the rotating
rod were recorded as a measure of running performance
for each trial and averaged for each group.
Narrow beam walk test
Narrow beam walk test was used to measure locomotor
coordination and grip strength as described by Goldstein
and Davis in 1990. Rats were trained on a 1 m long and
1–2 cm wide beam to transverse from a platform at one
end to the dark home cage at the other end. The apparatus
was placed horizontally 30 cm above the floor. The num-
ber of foot slips was recorded and the time taken to trans-
verse the beam was recorded. The score of two successful
trails was added and averaged for each animal in a group.
Novel Object Recognition (NOR) test
All the rats were subjected to NOR test for testing their
object recognition working memory. The rats were
habituated to the empty box (100 × 50 × 50 cm) for 5 min
over 2 days at the start of dark phase. The activities of the
rats were recorded by a video camera. Rats were allowed to
explore the open box during the habituation phase for
5 min followed by the familiarization phase during which
rats were placed in the box with two similar objects with-
out having any specific odour and were allowed to explore
both the objects for 5 min up to 3 days. The objects were
cleaned thoroughly with 70% ethanol to ensure the absence
of olfactory cues. On the test phase, the least preferred ob-
ject was replaced by the novel object to check the recogni-
tion memory of the rats. Between each phase, there was a
gap of 24 h. The exploration of object was defined by sniff-
ing, licking, chewing by rats or by moving vibrissae while
directing the nose towards and less than 1 cm from the ob-
ject. The number of episodes and time spent in exploration
of each object by each animal was recoded. The preference
index between the two objects was calculated as
Preference Index ¼ Time spent in exploring new object=Total time in exploration
We further analyzed grooming and rearing behavior in
rats in the open field box during NOR test to correlate the
effect of stress and anxiety caused by DIO on memory
and cognition. Any grooming bout of duration more than
5 s was recorded as actual grooming bout. Total time
spent in grooming and rearing activity was recorded using
video recording and averaged for each group.
Immunohistochemistry
For immunostaining of PSA-NCAM in dentate gyrus
(DG) region of hippocampus and pyriform cortex, ex-
perimental rats (n = 3) for each group were transcardially
perfused with 4% paraformaldehyde (PFA) in 0.1 M
phosphate buffer saline (PBS). Brains were dissected and
incubated in the fixative (4% PFA) for overnight at 4 °C
and subsequently cryopreserved in 20% and then 30%
sucrose for 24 h each at 4 °C. Coronal sections of 35 μm
were cut using cryostat microtome and treated as de-
scribed in our previous study [22].
Western blotting
Rats (n = 3–4 for each group) were anesthetized using
thiopentone injection (1 unit per 10 g) and sacrificed to
dissect out brain from the animal. Pyriform cortex (PC)
and hippocampus regions were dissected out and lysed
in lysing buffer using tissue homogenizer and centri-
fuged at 5000 rpm for 10 min at 4 C. Supernatant was
collected after centrifugation and used for protein esti-
mation by Bradford method. 50 μg of protein from each
sample was mixed with 6X sample buffer. Protein sam-
ples were resolved in 7–10% SDS-PAGE as per their mo-
lecular weight for better resolution, followed by transfer
onto a 0.45 μm pore size PVDF membrane (Hybond-P
from Amersham Biosciences UK Limited) using the
semi-dry Novablot system (Amersham Biosciences UK
Limited) at 90 mA for 90 min. Transferred membranes
were then blocked with 5% skimmed milk in 0.1% TBS-
Manchanda and Kaur BMC Complementary and Alternative Medicine  (2017) 17:136 Page 3 of 13
Tween 20 for 2 h. Further, membranes were probed with
mouse monoclonal anti-PSA-NCAM (1:1500), anti-
NCAM (1:2000), anti CaMKIIα (1:2000), anti CaN
(1:2000) anti-phospho Akt-1 (1:2000), (Sigma-Aldrich St.
Louis, MO, USA), anti-c-Jun (1:2000), anti-c-fos (1:2000)
(Santa Cruz Biotechnology Inc., USA), for overnight at
4 °C. This was followed by three washing with 0.1%
TBS-Triton-X 100 of 10 min each and incubation with
HRP-labeled anti-mouse IgM (1:2000) or anti-rabbit IgG
(1:5000) or anti-mouse IgG (1:5000) secondary anti-
bodies (Genei) for 2 h at 25 C. The remaining procedure
was followed as described in our previous study [22].
mRNA expression analysis by Quantitative Real time PCR
(RT-PCR)
Total RNA was extracted from the cells by TRI reagent
(Sigma-Aldrich) according to manufacturer’s instruc-
tions. For cDNA synthesis, 5 μg of RNA, 1 μl of 250 ng
(N6) random hexamer (Applied Biosystem), 1 μl of
dNTP mix (10 Mm of each dNTP (Amersham), nuclease
free sterile water upto 12 μl, 4 μl 5X first strand buffer,
2 μl of 1 M DTT, 1 μl of of recombinant ribonulease
inhibitor (40 units/ μl) (Invitrogen), 1 μl of 200 U of
M-MLV reverse transcriptase (Invitrogen) were added for
20 ul reaction volume. 50 μg of cDNA was then used to
amplify a gene of interest using StepOne Plus Real Time
PCR system (Applied Biosystems). Each 5 μl reaction mix-
ture comprised of 2.5 μl of 2X SYBR green Master Mix,
1 μl of 20× predesigned Primer mix (Applied Biosystem)
and of 1 μl water and 1 μl (50 μg) cDNA. GAPDH was
used as an endogenous control for each gene of interest.
The relative gene expression of each gene was calculated
by ‘Livak method’ and represented as 2 −ΔΔCt and final
gene expression as 2 −ΔΔCt ± SEM.
Statistical analysis
Values were expressed as mean ± SEM of the values ob-
tained from at least three independent experiments. The
Sigma Stat for Windows (version 3.5) was used to
analyze the results by Student’s t-test, one -way ANOVA,
two-way ANOVA (Holm-Sidak post hoc method), in
order to determine the significance of the mean values.
Results
Body weight, blood glucose and corticosterone
A gradual increase in the body weight was observed in
rats fed with their respective diets and on completion of
diet regimen, HFD rats weighed 24% more than the LFD
rats. Interestingly, the percentage weight in LFDE rats
was reduced to 15% compared to LFD alone group,
whereas, body weight was similar in HFD and HFDE
groups (Fig. 1a). Further, the blood glucose levels
showed no significant change between the groups
(Fig. 1b). Corticosterone levels were significantly higher
in HFD rats compared to LFD rats and supplementation
of ASH in HFDE group normalized the up regulated
levels of corticosterone to basal levels (Fig. 1c).
Behavioral studies
Locomotor coordination
Animals were tested for their locomotor skills on rotarod
and were accessed for their latency to fall from the cylin-
drical rod and the time spent on the rod. HFD rats showed
maximum number of falls and spent significantly less time
(p ≤ 0.05) on rotating rod compared to other three groups
indicating impaired locomotor function in these rats (Fig. 1d
and e). However, LFDE and HFDE rats showed lower la-
tency to fall from the rod (p ≤ 0.05), indicating reversal to
normal locomotor function (Fig. 1d and e). During narrow
beam walk test, rats were assessed for the time taken to
transverse the narrow beam and the frequency of paw slip-
page. HFD rats showed maximum paw slippage (p ≤ 0.01)
and took longer time to transverse the beam compared to
LFD rats (Fig. 1e and f). HFDE rats transversed the beam
very fast with negligible paw slippage with score of less than
1 (p ≤ 0.01) (Fig. 1f and g), thus indicating their strong grip
over the beam and intact locomotor function.
Novel object recognition test
Rats were subjected to NOR task to test their recogni-
tion memory and learning. HFD rats showed impaired
memory in recognizing the novel object compared to
LFD, LFDE and HFDE counterparts as evident from
their significantly higher number of episodes and time
spent in exploring the old object compared to the novel
object (p ≤ 0.05) indicating their impaired recognition
memory (Fig. 2a and c). On the contrary, HFDE rats
spent more time (p ≤ 0.05) in exploring the novel object
over the old one which was better than LFD group, thus
indicating their intact memory (Fig. 2c). Likewise, these
rats showed higher preference for the novel object
(p ≤ 0.01) with preference index (PI) score of more than
0.5, further supporting their intact recognition memory
whereas HFD rats failed to show their preference for the
novel object and had PI score of less than 0.5 (Fig. 2b).
Interestingly, HFD rats showed highest frequency of
grooming bouts (p ≤ 0.01) and spent maximum time in
grooming during NOR test indicating high stress/anxiety
levels of these rats compared to the other groups (Fig. 2d
and e). Compared to HFD rats, HFDE rats showed nor-
mal grooming behavior with very low frequency which
was even better than LFD and LFDE groups indicating
their low stress levels (Fig. 2d and e). Additionally, rats
were assessed for their rearing behavior also, wherein
HFD rats showed comparable frequency of rearing to
LFD rats, whereas, LFDE and HFDE rats showed higher
frequency of rearing (p ≤ 0.05) indicating their interest in
exploring the empty box (Fig. 2f ).
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Synaptic plasticity and cell survival markers
Hippocampal synaptic plasticity and spatial memory are
among very well reported brain functions which are
known to get seriously impaired by genetic and DIO.
The expression of some plasticity markers involved in
synaptic transmission and plasticity were studied from
hippocampus and PC regions. HFD rats showed increase
in the expression of PSA-NCAM compared to the LFD
rats and it was seen to be normalized with ASH treat-
ment in HFDE rats (p ≤ 0.05) in both the brain regions
(Fig. 3a and b). The expression of NCAM was down reg-
ulated in HFD rats, whereas it was significantly up regu-
lated in LFDE and HFDE rats in both the brain regions
at both the transcriptional and translational levels
(Fig. 3c, d–g). Further, the expression of calcium and
calmodulin dependent protein kinase, CaMKIIα was re-
duced significantly in HFD rats in both the brain regions
which was normalized in LFDE and HFDE rats by ASH
(Fig. 3c second panel, d and e). The expression of pro-
tein phosphatase CAN remained unaffected in hippo-
campus region while it was down-regulated in PC region
in HFD rats (Fig. 3c third panel, d and e). ASH treat-
ment was seen to prevent the decrease in expression of
CAN in PC region (Fig. 3c third right panel and e).
Phosphorylation of Akt at ser 473 is known to be im-
portant event in PI3K mediated synaptic plasticity and
memory consolidation [24]. Phosphorylation of Akt-1
was reduced in HFD rats while it was recovered in LFDE
and HFDE rats in both the brain regions (Fig. 4a and b).
The expression of IEGs such as c-jun and c-fos was
Fig. 1 Comparison of body weight, blood glucose, corticosterone and analysis of locomotor coordination tests. HFD regimen significantly increase the
body weight in HFD and HFDE rats (a) compared to control rats. A significant reduction in the body weight was found in LFDE rats (a). Blood glucose
levels remained unchanged between the groups (b). Corticosterone levels were significantly increased in HFD rats and restored to control levels in
HFDE rats (c). During rotarod test, ASH treated HFD rats performed better than HFD rats during as assessed by latency to fall (d) and time spent (e) on
rotarod. HFDE rats also performed better than HFD rats during narrow beam walk test as assessed by the paw slippage (f) and time taken (g) to
transverse the beam indicating their intact locomotor functions. Values are expressed as ± SEM, *p < 0.05 LFD vs. HFD, LFDE and HFDE, #p < 0.05 LFDE
and HFD rats, ¶p < 0.05 HFDE vs. HFD rats, $signifies highly significant levels. Holm sidak post-hoc test after one-way ANOVA
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down-regulated in HFD rats, while it was up regulated
in LFDE and HFDE rats in hippocampus region (Fig. 4a
left panel and b). In PC region, the expression of c-Jun
showed no change between the groups, whereas, c-fos
expression was markedly decreased in HFD rats and was
up regulated in LFDE and HFDE rats (p ≤ 0.05) (Fig. 4a
right panel and b).
Quantitative Real-time PCR expression of brain derived
neurotrophic factor and PI3/AKT pathway
The expression of BDNF and TRKB was found to be
down regulated in HFD rats while ASH treatment was
observed to compensate for the decreased expression in
LFDE and HFDE rats in hippocampus region (Fig. 4c).
The phosphotyrosine residues of TRKB receptor
Fig. 2 Analysis of various parameters during recognition memory test. Novel object recognition test performance is shown in a-f. HFD rats
showed significantly less number of episodes in exploring the new object than old one (a) compared to control rats, whereas HFDE rats spent
more time and episodes in exploring the new object as compared to HFD rats (a and c) indicating their intact recognition memory. Significant
difference in the preference index among HFD and HFDE group rats indicates the preference of the ASH treated HFD rats for the novel object
(b). HFD rats spent more time in grooming with significantly higher percentage of grooming bouts compared to control rats (d and e) indicating
their high stress levels. No significant change was found in the number of rearings among all the groups except HFDE rats with highest rearing activity
(f). Values are expressed as ± SEM, *p < 0.05 LFD vs. HFD, LFDE and HFDE, #p < 0.05 LFDE and HFD rats, ¶p < 0.05 HFDE vs. HFD rats, βp < 0.05 old vs
new within a group, €p < 0.05 LFD vs HFD within old, $signifies highly significant levels. Holm sidak post-hoc test after one way and two-way ANOVA
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functions as binding site for recruiting certain signaling
and scaffolding proteins that in turn activate Ras (a
family of guanosine nucleotide binding proteins that
control intracellular signaling events). In HFD rats, the
mRNA expression of Ras was significantly down regu-
lated in hippocampus region, which on treatment with
ASH was normalized to basal levels in LFDE and
HFDE rats (p ≤ 0.01) (Fig. 4c). Ras further activates
PI3K/AKT pathway in addition to other signaling net-
works. The expression of PI3K was down regulated in
both HFD and HFDE rats, whereas, in LFDE rats, it was
found to be markedly increased in hippocampus region
(Fig. 4c). Real time mRNA expression of total Akt-1 was
down regulated in HFD rats, while it was up regulated in
LFDE and HFDE rats in hippocampus region (Fig. 4c).
The mRNA expression of c-Jun was increased 1.5 fold in
HFD rats and was further increased to 2.5 fold in LFDE
rats compared to LFD group, whereas, in HFDE rats, the
expression was normalized to basal levels in hippocampus
region (p ≤ 0.01) (Fig. 4c). The expression of c-fos was
Fig. 3 Quantitative analysis of synaptic plasticity markers. Representative immunohistochemical images of PSA-NCAM (a), representative western
blot images and densitometric analysis of PSA-NCAM (b), representative protein bands and densitometric analysis of NCAM, CaMKIIα, and CAN
(c, d and e) and histograms representing fold change in expression of NCAM (f and g) in hippocampus and pyriform cortex (PC) regions of rat
brain among the three groups (n = 3 for each group). *p < 0.05 LFD vs. HFD, LFDE and HFDE rats, #p < 0.05 LFDE vs. HFD rats, ¶p < 0.05 HFDE vs.
HFD rats. Holm-sidak test after one-way ANOVA. Scale bar-200 μm
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slightly down regulated in HFD rats, whereas 1.5–2.5 fold
increase in the expression of this IEG was observed in
LFDE and HFDE rats from hippocampus and PC regions
(Fig. 4c and d).
In PC region, a slight increase in expression of BDNF
was observed in HFD and LFDE rats, whereas in HFDE
rats, a 6-fold increase was found in its expression (Fig. 4d).
The expression of TRKB was down regulated in HFD rats,
while it was significantly increased in LFDE and HFDE rats
(Fig. 4d). A marked decrease in the expression of Ras was
observed in HFD, LFDE and HFDE groups compared to
LFD rats (p ≤ 0.001) (Fig. 4d). The expression of PI3K was
significantly down regulated in HFD rats and was normal-
ized in LFDE and HFDE rats (Fig. 4d). No change in the
expression of Akt-1 was found among HFD, LFDE and
HFDE rats compared to LFD group (Fig. 4d) in this brain
region. The expression of c-Jun was decreased in HFD,
LFDE and HFDE groups compared to LFD group (Fig. 4d).
Fig. 4 Quantitative mRNA expression analysis of genes involved in BDNF mediated synaptic plasticity and cell survival. Representative immunoblots
(a) and densitometric analysis (b) of markers involved in cell survival such as Akt-1, c-Jun and c-fos in hippocampus and pyriform cortex regions of rat
brain. Quantitative mRNA expression of BDNF, TRKB, RAS, PI3K, Akt-1, c-Jun and c-fos in hippocampus (c) and pyriform cortex (d) regions of rat brain
among the four groups (n = 3 for each group).*p < 0.05 LFD vs. HFD, LFDE and HFDE rats, #p < 0.05 LFDE vs. HFD rats, £p < 0.05 LFDE vs. HFDE rats,
¶p < 0.05 HFDE vs. HFD rats, $signifies highly significant levels. Holm-sidak test after one-way ANOVA
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Discussion
The present study provides evidence that 12 weeks of
HFD regimen initiated in young adult female rats caused
no hyperglycemic condition but showed significant im-
pairment in their memory and locomotor functions.
These observations are supported by previous studies
reporting that HFD feeding developed no hyperglycemia
in females as compared to their age matched male coun-
terparts [25]. Estradiol levels in female mice have been
proposed to be one of the reasons for the absence of
hyperglycemia as compared to male mice [26]. However,
in rats, no change in the estradiol levels has been re-
ported in obese group of both the sexes. Based on previ-
ous studies data, it may be suggested that hyperglycemic
condition in males is attributed to their less energy ex-
penditure as compared to females on HFD despite the
similar energy intake requirements in both males and
females [25, 27]. Interestingly, ASH consumption was
observed to manage body weight gain in rats on regular
chow diet, whereas, HFD regimen masked the weight re-
ducing effect of ASH in HFDE rats. A recent clinical study
on root extract of Ashwagandha has reported the body
weight management in adults under chronic stress by re-
ducing the serum cortisol, physiological and psychological
stress thereby improving the eating behavior [28].
ASH prevented the memory related cognitive
impairments and maintained locomotor coordination in
HFD rats
During locomotor coordination studies, HFD rats
showed both lack of interest and strength in performing
these tasks as evident from higher number of falls and
less time spent on the rotating rod. ASH treated LFDE
and HFDE rats (Fig. 1d and e) performed as good as
LFD rats, thus indicating their normal neuromuscular
coordination. During narrow beam walk test, HFD rats
were observed to have poor balance over the narrow
beam and showed high percentage of paw slippage com-
pared to LFD and HFDE rats (Fig. 1f ). Further HFD rats
took longer time to transverse the entire beam, whereas,
LFDE and HFDE rats spent time almost equal to LFD
group to transverse the beam (Fig. 1g) indicating their
intact locomotor functions. These observations from the
behavioral studies indicated that HFD regimen caused
locomotor and neuro-muscular dysfunction and ASH
have the potential to improve motor performance and
body balance in rats on HFD regimen.
During novel object recognition task, HFD rats
showed impairment in their recognition and working
memory as is suggested by higher number of episodes in
exploring the old object over the novel one (Fig. 2a) and
less time spent in exploring the novel object (Fig. 2c).
Both LFDE and HFDE rats performed better as they
spent more time in exploring the novel object compared
to the old one (Fig. 2c). These observations were
strongly supported by the PI score of the rats (Fig. 2b).
The HFD rats showed least preference for the novel ob-
ject (PI ≤ 0.5), whereas ASH supplemented rats showed
more preference for the novel object (PI ≥ 0.5) (Fig. 1b).
A PI score of less than 0.5 shows no preference for any
of the objects and more than 0.5 score shows preference
for the novel object [29]. Further, we studied grooming
behavior in these rats during NOR test and observed
that HFD rats showed higher percentage of grooming
bouts, whereas LFDE and HFDE groups showed similar
percentage of grooming bouts to LFD animals (Fig. 2d).
Grooming is a nonspecific behavior that serves a broad
range of purposes [30]. In rodents, grooming is an im-
portant behavioral repertoire and is associated with their
adaptation to stress conditions as well as to self-cleaning
[31]. Rodents generally follow a well ordered and se-
quential grooming pattern starting from rostrum up to
tail under low stress conditions. Conversely, animals
with high stress/anxiety levels display fragmented
grooming pattern [31, 32]. In other words, self-grooming
with non-structured pattern is considered as a marker of
increased anxiety like behavior. In our study, HFD rats
spent maximum time in grooming with interrupted and
fragmented pattern paralleled by high number of groom-
ing bouts, thus indicating their anxiogenic behavior.
However, ASH supplemented rats showed least groom-
ing activity coupled to a sequential grooming pattern as
compared to HFD rats (Fig. 2e), thus suggesting the
anxiolytic potential of ASH powder.
These observations are also supported by the rearing
activity of the ASH supplemented rats as these were ob-
served to show maximum rearing episodes compared to
LFD and HFD rats (Fig. 2f ). Rearing is the innate ex-
ploratory behavior found in rodents under most of the
environmental conditions and is considered as a marker
of environmental novelty that can be used to measure
hippocampal learning and memory task [33]. Increased
levels of corticosterone also support the higher stress
levels and metabolic abnormalities in rats fed with HFD
regimen, whereas, ASH feeding restored the basal levels
of the stress hormone and the metabolic state in HFD
rats (Fig. 1c). Since serum corticosterone levels were an-
alyzed irrespective of the phase of estrous cycle, it may
be possible that the different phases of estrous cycle
have also contributed to these changes. However, a re-
cent study carried out on high fat diet induced obesity
has reported an increase in corticosterone levels in
young adult male and female rats [34]. Several other
studies in HFD induced obesity model have reported in-
creased levels of corticosterone and their metabolites in
obese rats which along with insulin increased the fat
stores and contributed to obesity due to high caloric
intake [35, 36]. Both basic and clinical research has
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reported memory retention and memory enhancing
role of aqueous and alcoholic formulations from root
of Ashwagandha [37–39]. Aqueous leaf extract of
Ashwagandha has been recently reported by our lab to
improve memory retention functions by reducing the cel-
lular stress via ameliorating the synaptic plasticity and cell
survival pathways in acute sleep deprived rats [23]. Based
on these observations, it may be suggested that ASH sup-
plementation reduced the stress levels and exhibit noo-
tropic effect in HFD induced obese rats.
ASH suppressed the change in synaptic plasticity markers
induced by high fat diet regimen
Cognitive impairments are known to be the outcomes of
alterations in hippocampal synaptic plasticity thus
affecting learning performance and memory functions.
Experiments to discern the underlying molecular mech-
anism of these alterations revealed up regulation in the
expression of PSA-NCAM in hippocampus and PC re-
gions of brain with HFD regimen (Fig. 3a and b). It has
been reported that chronic restraint stress up-regulates
the expression of PSA in DG and pyriform cortex re-
gions of brain while inhibiting the process of neurogen-
esis [40, 41]. The enhanced polysialylation in HFD
animals may be a neuroprotective mechanism in stress
vulnerable neuronal circuits promoting the structural re-
covery and integrity. However, ASH treatment compen-
sated for the stress induced increase in the expression of
PSA-NCAM in HFDE rats (Fig. 3a and b). It has been
reported that PSA is required for the basal synaptic
transmission of new neurons but not in synaptic potenti-
ation, which is solely dependent on NCAM expression
[42]. A very recent study has reported that increased ex-
pression of NCAM1 with donepezil (acetylcholinesterase
inhibitor) and aniracetam (nootropic) improved spatial
memory in status epilepticus rats [43]. The poor recog-
nition memory of HFD fed rats might be attributed to
decreased expression of NCAM and ASH treatment sig-
nificantly increased the mRNA and protein expression
of NCAM (Fig. 3c, d–g), thereby improving the perform-
ance of LFDE and HFDE rats in memory task observed
in the current study.
Further, the expression of CaMKIIα was evaluated as
it is highly implicated as an initial signaling event in long
term memory storage and its constitutive exposure to
neurons is known to produce synaptic enhancement. It
has been reported that there is reduction in the level of
total CaMKIIα in DG and CA1 regions of hippocampus
in obese zucker indicating the impairment of synaptic
potentiation in hippocampus specifically in the CA1
region [44]. In the present study, the expression of
CaMKIIα was significantly down regulated in rats on
HFD regimen in both the brain regions (Fig. 3c, d–e) in-
dicating the impairment in calcium mediated synaptic
plasticity. ASH supplementation in LFDE and HFDE rats
up regulated the expression of CaMKIIα in both the
brain regions (Fig. 3c, d–e) indicating the conditions,
permissive for synaptic enhancement. Another import-
ant regulator of synaptic plasticity is calcineurin and it
has been reported that overexpression of calcineurin ac-
tivate long term depression [45, 46]. In our study, we
found no change in the protein expression of CAN be-
tween all the treatment groups compared to LFD rats in
hippocampus region (Fig. 3c and d), whereas, in PC
region, it was decreased in HFD rats and remained un-
changed in LFDE and HFDE (Fig. 3c and e). This reduc-
tion in PC region could be due to a compensatory
mechanism in HFD rats against the reduced expression
of total CaMKIIα and due to divergent nature of neu-
rons existing in the two regions.
Based on the changes in the synaptic plasticity mole-
cules in the current study, it may be suggested that poor
performance of HFD rats in NOR and locomotor coord-
ination tests could be due to their impaired synaptic
function. However, ASH supplementation restored the
synaptic function by maintaining the optimal expression
of NCAM and its polysialylated form, CaMKII (all
implicated in synaptic transmission and learning and
memory) thereby improving the performance of rats
during the behavioral tasks.
BDNF/PI3K/AKT pathway mediated modulation of
synaptic plasticity in high fat diet regimen
High caloric diet is known to impair learning and mem-
ory by modulating synaptic plasticity and neurogenesis
accompanied by reduction in the BDNF levels and den-
dritic spine density in hippocampus of the rats. Long
term HFD feeding reduced the BDNF and its tyrosine
receptor TRKB levels in hippocampus region of the
brain (Fig. 4c) indicating that reduction in the synaptic
plasticity in HFD rats may be mediated by the BDNF
pathway. Several studies have reported that impaired
cognitive functions and hippocampal neurogenesis in
middle aged rats and in young offspring’s of the mother
under high caloric regimen are mediated by reduced
BDNF levels [47, 48]. Interestingly, ASH supplementa-
tion recovered the BDNF and TRKB levels in the LFDE
and HFDE rats (Fig. 4c), indicating the restoration of the
hippocampal function of learning and memory and
synaptic plasticity. Treadmill exercise has been recently
reported to improve the cognitive functions in high fat
diet induced obese mice by improving the levels of
BDNF and TRKB in hippocampus region of brain [4].
The better performance of ASH supplemented rats in
learning and memory tasks may be due to their en-
hanced BDNF and TRKB levels in the hippocampus. In
PC region, the expression of BDNF was increased in all
the groups compared to LFD rats (Fig. 4d) which could
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be due to differential expression and synthesis of this
neurotrophic factor in the two brain regions as sup-
ported by previous studies [49, 50]. The expression of
TRKB was decreased in HFD rats and ASH supplemen-
tation restored the expression of TRKB to normal levels
(Fig. 4d) similar to hippocampus region.
Neurotrophins are known to promote neuronal survival
by Ras dependent activation of PI3 Kinase which in turn
phosphorylates Akt to promote cell survival and inhibit
apoptosis. PI3K/AKT is the principal signaling pathway
that allows the cell to withstand apoptotic stimulus and
promote cell survival. Down-regulation in the expression
of PI3K gene in HFD rats (Fig. 4c and d) may be due to
the inhibition of cell survival signal, which was restored to
LFD levels in ASH supplemented rats (Fig. 4c) thus, sug-
gesting the activation of cell survival signaling events in
these rats. Likewise, the gene expression level of total and
phosphorylated Akt-1 was down regulated in HFD rats
further confirming the suppression of cell survival signal
in these animals (Fig. 4a–d). ASH supplementation en-
hanced the expression of total and phosphorylated Akt-1
in LFDE and HFDE rats in both the brain regions, thereby
promoting the survival conditions in the neuronal cells.
Similarly, the expression of c-Jun and c-fos (IEGs in the
cell survival mechanism) was suppressed in HFD rats
(Fig. 4a–d), while ASH supplementation restored the ex-
pression levels of these transcription factors, specifically in
hippocampus region (Fig. 4a left panel and b). In PC re-
gion, we observed activation of cell survival molecules but
the changes were more prominent in hippocampus region.
The possible reason for this differential response might be
due to profound modulation of structural and functional
plasticity and subsequent activation of survival molecules
in hippocampus region as compared to the PC region.
Stress induced activation of glucocorticoids are known to
strongly inhibit the hippocampal BDNF expression in
Fig. 5 Schematic representation of the study. HFD regimen ameliorated key synaptic and cell survival pathways and ASH supplementation
reduced stress levels and may have prevented memory and neuro-motor impairments caused due to HFD regimen. ASH exhibits a pleotropic
neuroprotective phenomenon by targeting key pathways such as modulating BDNF mediated synaptic plasticity and cell survival in discrete brain
regions, thereby promoting overall health and vitality
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HFD rats [51, 52]. So it may be suggested that reduction
in the BDNF expression may be linked to enhanced ex-
pression of corticosterone in HFD rats. BDNF enhances
efficiency of synaptic transmission and hippocampal syn-
aptic plasticity by activating CaMKII in hippocampus re-
gion thereby improving the cognitive performance [53]. In
conclusion, it may be suggested that ASH treatment im-
proved the memory and learning based functions by pro-
moting the activity dependent hippocampal plasticity and
cell survival and by reducing the cellular stress (schematic
representation of the possible molecular pathways in ASH
mediated activity in HFD rats in Fig. 5).
Conclusions
Obesity has been associated with the progressive cognitive
decline and impairments in the synaptic plasticity and po-
tentiation by interplay between neurotropic factors and
oxidative stress [54]. Ashwagandha as an ayurvedic formu-
lation have been known for decades for its rejuvenating
and life prolonging effects thereby promoting health and
survival. The current data may suggest that HFD regimen
impaired recognition memory and locomotor balance and
ASH supplementation improved the behavioral outcomes
of learning and memory as well as locomotor coordination
in Wistar rats, thereby promoting neuroplasticity. The
possible mechanism of ASH may be via BDNF mediated
synaptic modulation and AKT mediated cell survival
(Fig. 5). These observations validate the traditional use of
Ashwagandha as nootropic candidate which seems to play
a key role in maintaining the synaptic plasticity in HFD in-
duced obesity and may serve as a potential candidate
against obesity induced cognitive impairments.
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